Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Banks

Showing results (341-350 of 361) with videos related to

Pageof 37
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2018
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challengeC M Parseghian, J M Loree, V K Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Austin L Chien, et al.
Nature Communications|July 17, 2021
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNABelinda Kingston, Rosalind J Cutts, Hannah Bye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patientsS T Kim, K C Banks, E Pectasides, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 17, 2020
Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver MutationsMarcelo V Negrao, Victoria M Raymond, Richard B Lanman, et al.
Communications Biology|February 23, 2019
Biotic interactions are an unexpected yet critical control on the complexity of an abiotically driven polar ecosystemCharles K Lee, Daniel C Laughlin, Eric M Bottos, et al.
Biological Reviews of the Cambridge Philosophical Society|December 20, 2018
Animal movements in fire-prone landscapesDale G Nimmo, Sarah Avitabile, Sam C Banks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast CancerCynthia X Ma, Ron Bose, Feng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2019
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNAAhmed O Kaseb, Nora S Sánchez, Shiraj Sen, et al.
Nature Genetics|November 7, 2017
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancersCollin M Blakely, Thomas B K Watkins, Wei Wu, et al.
Pageof 37

Showing results (341-350 of 361) with videos related to

Sort By:
Pageof 37
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2018
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challengeC M Parseghian, J M Loree, V K Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Austin L Chien, et al.
Nature Communications|July 17, 2021
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNABelinda Kingston, Rosalind J Cutts, Hannah Bye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patientsS T Kim, K C Banks, E Pectasides, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 17, 2020
Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver MutationsMarcelo V Negrao, Victoria M Raymond, Richard B Lanman, et al.
Communications Biology|February 23, 2019
Biotic interactions are an unexpected yet critical control on the complexity of an abiotically driven polar ecosystemCharles K Lee, Daniel C Laughlin, Eric M Bottos, et al.
Biological Reviews of the Cambridge Philosophical Society|December 20, 2018
Animal movements in fire-prone landscapesDale G Nimmo, Sarah Avitabile, Sam C Banks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast CancerCynthia X Ma, Ron Bose, Feng Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2019
Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNAAhmed O Kaseb, Nora S Sánchez, Shiraj Sen, et al.
Nature Genetics|November 7, 2017
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancersCollin M Blakely, Thomas B K Watkins, Wei Wu, et al.
Pageof 37